AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENT between SALIX PHARMACEUTICALS, INC. and GLENMARK PHARMACEUTICALS LTD. Dated as of July 18, 2011Manufacturing Agreement • November 9th, 2011 • Salix Pharmaceuticals LTD • Pharmaceutical preparations • New York
This AMENDED AND RESTATED MANUFACTURING AND SUPPLY AGREEMENT (this “Agreement”), dated as of July 18, 2011 (the “Amendment Effective Date”), is made by and between Salix Pharmaceuticals, Inc., a California corporation (“Salix”), and Glenmark Pharmaceuticals Ltd., a corporation organized under the laws of India (“Glenmark”). Salix and Glenmark are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
AGREEMENT FOR ADVANCE AGAINST COMMITMENT FEEAdvance Against Commitment Fee Agreement • November 9th, 2011 • Salix Pharmaceuticals LTD • Pharmaceutical preparations • New York
This Agreement for Advance Against Commitment Fee is made on this 18th day of July, 2011 (the “Advance Agreement” or this “Agreement”)
THIRD AMENDMENT TO LEASELease Agreement • November 9th, 2011 • Salix Pharmaceuticals LTD • Pharmaceutical preparations
THIS THIRD AMENDMENT TO LEASE (this “Third Amendment”) is entered into as of the 18th day of October, 2011 by and between EOS ACQUISITION I LLC, a Delaware limited liability company (“Landlord”), and SALIX PHARMACEUTICALS, INC., a California corporation (“Tenant”). Capitalized terms not otherwise defined herein shall have the meaning set forth in the Original Lease (hereinafter defined).
